Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial.
Blood Cancer J
; 11(12): 197, 2021 12 07.
Article
in En
| MEDLINE
| ID: mdl-34876566
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Boron Compounds
/
Antineoplastic Combined Chemotherapy Protocols
/
Glycine
/
Multiple Myeloma
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Blood Cancer J
Year:
2021
Document type:
Article
Affiliation country:
Italy